Yan Xie
- Rehabilitation top 2%
- Wound Healing and Treatments 11
-
- Lymphoma Diagnosis and Treatment 50
- Oncology top 5%
- Viral-associated cancers and disorders 22
- CAR-T cell therapy research 9
- Dermatology top 5%
- Dermatologic Treatments and Research 5
- Immunology top 10%
- Immune Cell Function and Interaction 9
-
- CNS Lymphoma Diagnosis and Treatment 15
-
- Chronic Lymphocytic Leukemia Research 10
- Co-authors
- Jun ZhuYuqin SongZee UptonWen ZhengXiaopei WangNingjing LinDavid I. LeavesleyLingyan Ping
- Journals
- SHILAP Revista de lepidopterología (2 papers)Blood (2 papers)Biomaterials (1 paper)
In The Last Decade
Yan Xie
68 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Rehabilitation 190
- Pathology and Forensic Medicine 441
- Oncology 520
- Dermatology 143
- Immunology 231
Countries citing papers authored by Yan Xie
This map shows the geographic impact of Yan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xie more than expected).
Fields of papers citing papers by Yan Xie
This network shows the impact of papers produced by Yan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xie. The network helps show where Yan Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yan Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 50 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 0 | |
| 6 | Anticancer activity of 1, 25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway | 2019 | 1 |
| 7 | 2019 | 8 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 28 | |
| 10 | 2019 | 6 | |
| 11 | 2018 | 11 | |
| 12 | 2018 | 23 | |
| 13 | 2017 | 7 | |
| 14 | 2016 | 29 | |
| 15 | 2015 | 18 | |
| 16 | Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy | 2015 | 5 |
| 17 | 2010 | 85 | |
| 18 | Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma. | 2009 | 0 |
| 19 | 2008 | 69 | |
| 20 | 1989 | 98 |
About Yan Xie
Yan Xie is a scholar working on Pathology and Forensic Medicine, Rehabilitation and Oncology, having authored 78 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (50 papers), Viral-associated cancers and disorders (22 papers), CNS Lymphoma Diagnosis and Treatment (15 papers), Wound Healing and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (9 papers) and Dermatologic Treatments and Research (5 papers). The work is most often cited by research in Rehabilitation (190 citations), Pathology and Forensic Medicine (441 citations) and Oncology (520 citations). Yan Xie has collaborated with scholars based in China, Ethiopia and Australia. Frequent co-authors include Jun Zhu, Yuqin Song, Zee Upton, Wen Zheng, Xiaopei Wang, Ningjing Lin, David I. Leavesley, Lingyan Ping, Weiping Liu and Zhitao Ying. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.